Pretreatment Serum Level of Neuron Specific Enolase (NSE) as a Prognostic Factor in Metastatic Prostate Cancer Patients Treated with Endocrine Therapy

Objective: The serum level of neuron specific enolase (NSE) is gaining acceptance as a marker of neuroendocrine tumors. To clarify the role of NSE in prostate cancer progression, we examined the relationship of NSE to clinicopathological parameters. Methods: The pretreatment serum NSE level was meas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European urology 2003-09, Vol.44 (3), p.309-314
Hauptverfasser:	Kamiya, Naoto, Akakura, Koichiro, Suzuki, Hiroyoshi, Isshiki, Shinzou, Komiya, Akira, Ueda, Takeshi, Ito, Haruo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - blood Adenocarcinoma - diagnosis Adenocarcinoma - drug therapy Adenocarcinoma - pathology Aged Androgen Antagonists - therapeutic use Biomarkers, Tumor - blood Bone Neoplasms - secondary Endocrine therapy Follow-Up Studies Humans Male Multivariate Analysis Neoplasm Staging - methods Neuroendocrine differentiation Neuron specific enolase Phosphopyruvate Hydratase - blood Predictive Value of Tests Prognosis Prostate cancer Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology Retrospective Studies Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!